ARTICLES

PCSK9 inhibitors: ¿Quo Vadis? – The FOURIER Trial: an editorial comment 0
- ARTICLES
- abril 1, 2017
FOURIER is a mega-trial of clinical efficacy and safety of evolocumab added to treatment with moderate / high intensity statins in patients with clinically evident atherosclerotic cardiovascular disease (ASCVD).
LEER MÁS
World Heart Day 0
- ARTICLES
- septiembre 29, 2016
Today is World Heart Day and The Caribbean Cardiac Society joins the World Heart Federation and organisations around the world in encouraging the creation of healthy heart environments wherever people live, work and play.
LEER MÁS
HEART FAILURE COUNCIL 0
- ARTICLES
- agosto 8, 2016
STICHES: Coronary Bypass Surgery in Patients with Left Ventricular Dysfunction
LEER MÁS

Not another claim that salt reduction is controversial?0
- ARTICLES
- julio 11, 2016
The review by Yusuf and colleagues proclaims that ‘there is no convincing evidence that moderate intake of sodium (3-5 g /day*) is associated with increased risk of CVD compared with lower levels of sodium consumption’.
LEER MÁS
The New Definition of Early Repolarisation 1
- ARTICLES
- febrero 4, 2016
There has been an increasing interest in the electrocardiographic pattern of early repolarization in recent years following the publication of a paper by Haissaguerre and colleagues in 2008, which linked their definition of the pattern to sudden cardiac arrest due to idiopathic ventricular fibrillation. However, earlier and later publications by other groups on the topic
LEER MÁS
The important prognostic information provided by CMR post TAVR 0
- ARTICLES
- diciembre 16, 2015
Transcatheter aortic valve replacement (TAVR) has become an important procedure for treatment of aortic valve disease in a selected group of patients. Despite the initial success it is not uncommon for residual aortic regurgitation to remain a significant complication following the procedure.
LEER MÁS